Form D · Other Technology
HealthReveal, Inc.
New York, NY · CIK 0001641152
Offering snapshot reported Dec 24, 2019 · SEC filing
- Reported sold
- $26.6M Offering amount: $27M
- Investors reported
- 13 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Feb 1, 2017 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
- Reported sold$15,837,746 → $26,599,554
- Reported investors12 → 13
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 24, 2019 | Amendment | $26,599,554 | $10,761,808vs Jun 22, 2018 | 13 | SEC filing |
| Jun 22, 2018 | Amendment | $15,837,746 | $4,699,999vs Feb 9, 2017 | 12 | SEC filing |
| Feb 9, 2017 | Initial | $11,137,747 | No comparison | 9 | SEC filing |
| May 13, 2015 | Initial | $1,007 | No comparison | 5 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-280365
Series A Preferred Stock
Source: Form D, filed Dec 24, 2019. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Lori Evans Bernstein | Executive |
| Mark Keim | Executive |
| Frank Norman | Executive |
| Lonny Reisman | Director, Executive |
Issuer details
Industry: Other Technology (See others in industry)
Address:
750 Lexington Avenue
New York, NY, 10022
New York, NY, 10022